The PREVAIL trial and low-molecular-weight heparin for prevention of venous thromboembolism

被引:6
作者
Muir, Keith W. [1 ]
机构
[1] Univ Glasgow, So Gen Hosp, Inst Neurol Sci, Div Clin Neurosci, Glasgow G51 4TF, Lanark, Scotland
关键词
antiplatelet agents; venous thromboembolism;
D O I
10.1161/STROKEAHA.107.509588
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:2174 / 2176
页数:3
相关论文
共 13 条
[1]   Low-molecular-weight heparins and heparinoids in acute ischemic stroke - A meta-analysis of randomized controlled trials [J].
Bath, PMW ;
Iddenden, R ;
Bath, FJ .
STROKE, 2000, 31 (07) :1770-1778
[2]   Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial [J].
Bath, PMW ;
Lindenstrom, E ;
Boysen, G ;
De Deyn, P ;
Friis, P ;
Leys, D ;
Marttila, R ;
Olsson, JE ;
O'Neill, D ;
Orgogozo, JM ;
Ringelstein, B ;
van der Sande, JJ ;
Turpie, AGG .
LANCET, 2001, 358 (9283) :702-710
[3]   Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study [J].
Berge, E ;
Abdelnoor, M ;
Nakstad, PH ;
Sandset, PM .
LANCET, 2000, 355 (9211) :1205-1210
[4]  
Berge E, 2002, COCHRANE DB SYST REV, V4
[5]  
DESMUKH M, 1991, AM J PHYS MED REHAB, V70, P313
[6]   Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients [J].
Kamran, SI ;
Downey, D ;
Ruff, RL .
NEUROLOGY, 1998, 50 (06) :1683-1688
[7]   Natural history of venous thromboembolism [J].
Kearon, C .
CIRCULATION, 2003, 107 :I22-I30
[8]  
MCCARTHY ST, 1977, LANCET, V2, P800
[9]  
SANDERCOCK P, 2005, COCHRANE DB SYST REV, V2
[10]   The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venousthromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison [J].
Sherman, David G. ;
Albers, Gregory W. ;
Bladin, Christopher ;
Fieschi, Cesare ;
Gabbai, Alberto A. ;
Kase, Carlos S. ;
O'Riordan, William ;
Pineo, Graham F. .
LANCET, 2007, 369 (9570) :1347-1355